Barriers to overcoming immunotherapy resistance in glioblastoma
Glioblastoma multiforme (GBM) is the most common malignant primary brain tumor, known for its poor prognosis and high recurrence rate. Current standard of care includes surgical resection followed by combined radiotherapy and chemotherapy. Although immunotherapies have yielded promising results in h...
| Main Authors: | , , , |
|---|---|
| 格式: | Article |
| 語言: | English |
| 出版: |
Frontiers Media S.A.
2023-05-01
|
| 叢編: | Frontiers in Medicine |
| 主題: | |
| 在線閱讀: | https://www.frontiersin.org/articles/10.3389/fmed.2023.1175507/full |